

                                                                                                           Page 1 of 18
                        Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference




    Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference
                                                        New York Observer
                                                    January 13, 2020 Monday



Copyright 2020 The New York Observer, L.P. All Rights Reserved

Length: 12487 words
Byline: Arick Wierson and Beau Draghiciu

Body


On Monday, January 13, like a swarm of honey bees, thousands of health tech entrepreneurs, health care execs,
venture capitalists, bankers, regulators and business media will descend upon downtown San Francisco as the 38th
Annual J.P. Morgan Healthcare Conference gets under way. And, as is the case with any multi-day industry
gathering worth its salt, an entire ecosystem of satellite events has popped up around the main attraction, which
has created a seemingly endless circuit of networking events, summits and other health care-related shindigs-all
offering ample excuses to down lattes during the day and throw back a shot or two at night.

Even though only a select few are invited to attend the official main stage, marking one's presence at J.P. Morgan
is paramount, as the four-day confab has positioned itself as not only the first, but perhaps the most important event
of the global health care conference calendar year.

SEE ALSO: Revel Is Rewriting the Playbook on How Health Plans Talk to You

Ahead of last year's J.P. Morgan gathering, Observer was among the first to point out a trend that was beginning to
emerge across the health industry-the rise in interest from both large health care players, as well as hungry
venture capitalists, for health tech plays originating in cities not typically associated with startup culture, places like
Minneapolis, Nashville and Chicago. Observer even coined a new term for these disruptors from Middle America:
Flyover Tech.

And, judging by the pre-conference buzz, by all accounts, last year was not a fluke; many of the entries from the
2019 list have emerged as some of the biggest and most important players in their respective sectors over the past
12 months. Some of them have even carved out completely new niches within the vast health care ecosystem that
didn't exist a year ago.

As some informed observers of the high-flying health tech space quipped, "Flannel is the New Black," when it
comes to innovation in health care and big bets in health tech.

Take for example Bind, a Minneapolis-based startup health plan that has already raised a jaw-dropping $82 million.
After occupying last year's top position on the list for its ability to use data science and artificial intelligence (AI) to
analyze existing claims data, Bind had a banner year. The company has been expanding its services across
multiple new areas of coverage, while empowering customers to understand what they are really paying for with
their health plans, which makes it easy to compare treatment options, prices and quality. Bind, along with fellow

                                                                                                      Page 2 of 18
                     Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference

Minnesota wunderkind health insurance startup              Bright Health-which just announced the closing of
$635 million in Series D financing in December, on top of over $400 million of funding in previous rounds (putting its
total raise now over the billion dollar mark)-have chiseled out completely new offerings in the health insurance
space, a sector that, less than a decade ago, was considered nearly impenetrable due to the vast resources
needed to scale a business of that nature.

"It still amazes me the number of investors that haven't taken full advantage of the 'flyover tech' ecosystem,"
observed Jodi Hubler, managing director of Lemhi Ventures, a venture capital firm that invests primarily in early- to
mid-stage health companies in the Midwest and Rocky Mountain regions. "Many places in Middle America are
actually centers of innovation and deep domain knowledge not only in health care, but in medtech device and
services as well," added Hubler, referring to the largest players in health care and medtech, like UnitedHealth
Group, Medtronic, Cardinal Health, Humana and Anthem-all of which have main bases of operations in between
the coasts.

"It's common sense economics-every dollar of capital goes further in these locations, and the access to talent from
developers to board members comes with differentiated experience and knowledge," Hubler told Observer. "In
places like the Midwest, people don't play in health care, they've lived it... that experience and intuition is
invaluable."

Another big winner from last year's list was Nashville-based SmileDirectClub, a tele-dentistry startup that produces
direct-to-consumer 3D-printed clear aligners. In September, the teeth-straightening startup went public,
raising more than $1.3 billion at an initial market cap of roughly $10 billion, more than three times its most recent
private valuation. And although the stock price has since clawed back some of those ebullient IPO gains, it's yet
another shining example of a flyover tech success story.

Flyover Tech Is Now a 'Badge of Honor' in Health Tech

For serial health care entrepreneur and founder of San Francisco-based Roam Analytics Alex Turkeltaub, there is
gold to be mined in Middle America. "Hubs like Raleigh, Columbus and Nashville, just to name a few, are quickly
becoming known as exciting centers of innovation in health care. With strong legacy technology and health care
systems, it's only natural that these local ecosystems will fuel the next generation of disruptors in digital health,"
observed Turkeltaub, who recently stepped down as CEO of Roam and is setting up a venture fund that focuses on
the         intersection of AI and health care. The fund will look to make strategic investments in major health tech
hubs across the country, as well as in emerging overseas markets like Brazil.

"The term 'flyover' used to be somewhat derogatory, but now it's a badge of honor in health tech. Entrepreneurs in
the middle of the country know that technology can't exist for its own sake; it has to be combined with functional
business models to deliver real value to patients and investors alike," added Turkeltaub. "Any serious health care
VC who isn't making monthly visits to places like Minneapolis or Chicago is completely missing the boat."

Chicago, Nashville and Minneapolis Are Emerging as the New 'Silicon Valleys' of Health Tech

Although there are entries on this year's list from a wide swath of cities across the country, experts and insiders
repeatedly point to the surfeit of companies emerging from three major hubs of innovation in health care from
Middle America: Nashville, Chicago and the Twin Cities of Minneapolis and St. Paul.

"With a diverse set of headquartered legacy companies spanning the entire spectrum of health care, regional hubs
such as Nashville, Chicago and Minneapolis will continue to produce industry-leading innovation and transformation
in the sector. These are the new hotbeds in health care," noted Sara Ratner, a veteran health care industry insider
who is one of the nation's foremost experts on government-run Medicare and Medicaid programs.

Observer spoke with health care experts from across the U.S. to offer their thoughts about the biggest emerging
trends at the 2020 J.P. Morgan Healthcare Conference and the sector's continued interest in flyover tech. They
were also asked to highlight some of the hottest companies in between the two coasts that will be feted in San
Francisco this week. Like last year, the current list is not a ranking in the traditional sense-the companies singled

                                                                                                       Page 3 of 18
                     Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference

out are in different stages of development and growth and, for the most part, are positioned in non-competing
verticals; rather, the list is a snapshot of 20 early- to mid-stage startups that have caught the attention of health
care insiders from around the globe and have one thing in common: they all hail from what many a New Yorker
might describe as 'flyover country.'

And now, here is Observer's 20 Hottest Companies in 'Flyover Tech' at the 2020 J.P. Morgan Healthcare
Conference.

1. HistoSonics (Ann Arbor, Michigan); Capital Raised: $87 Million

Non-invasive cancer treatment. Let those words sink in. By using technology similar to an ultrasound, this new
interventional therapy will transform nearly all forms of cancer detection and eradication. In some respects, the
company's flagship product is not unlike the "healing machine"-the technology central to the plot to the 2013 Matt
Damon thriller Elysium set 134 years in the future.

Led by veteran health care executive Mike Blue, the company's non-invasive robotics platform and novel sonic
beam therapy is awaiting full FDA clearance, but the company has already announced reams of promising new
clinical and preclinical data, including successful human trials in Spain. In April of last year, HistoSonics closed a
$54 million C-Round led by Varian Medical Systems, Inc., the global leader in radiation therapy and oncology
solutions, and included          Johnson & Johnson Innovation and the          State of Wisconsin Investment Board,
among others. Initially targeting liver and pancreatic cancer, HistoSonics' Robotically Assisted Sonic Therapy
(RASTSM) combines advanced robotics and imaging with a proprietary sensing technology to deliver personalized
treatments with unparalleled precision and control. In layman's terms, the tech uses sound energy to generate
pressures strong enough to liquify and completely destroy targeted tissues at sub-cellular levels.

Meanwhile, HistoSonics is busy building a new HQ in a Minneapolis suburb. "Our tech was born in the labs of the
University of Michigan, but we quickly realized we needed to be at the epicenter of health care innovation, which is
why we decided to move our base to Minnesota," explained Blue. "This is where all the action is right now in health
tech."

2. Olive AI (Columbus, Ohio); Capital Raised: $72.8 Million

Over one trillion dollars are spent every year in the U.S. on health care administration. Not on doctors, needles,
meds or IVs, but on pens, paper, IT and something called 'system integration.' It's a huge outlay-and the fact that
much of that spend could be better directed toward treating patients and saving lives is what constitutes the driving
force behind Ohio-based startup Olive AI.

CEO Sean Lane and the team at Olive understand that hospital employee time is money, which is why in the last
year, their AI-powered workforce has become the utility player for over 500 individual hospitals around the U.S.,
handling high-volume, administrative workloads. Olive's automated workforce takes on the minutia of the often
repetitive paperwork that plagues nearly all sectors of health care-from human resources and IT to supply chain
management and revenue cycle tracking-allowing employees to focus on the important, big picture aspects of their
work. Convenient, efficient, fast and accurate, Olive AI is an overworked employee's dream assistant, and the
venture world, which has plowed over $70 million into the company thus far, seems to agree.

3. NightWare (Minneapolis, Minnesota); Capital Raised: Undisclosed

The highly secretive NightWare was on last year's hot list, and while it is still not disclosing its fundraising totals
(one of the advantages of not raising with institutional investors), the company continues to make big strides in the
treatment of PTSD and nightmare disorder, a condition affecting over five million Americans and hundreds of
thousands of U.S. vets. Over the past 12 months, NightWare received official "Breakthrough Status" designation by
the FDA, which is only given to treatments that, according to the FDA, "demonstrate substantial improvement on a
clinically significant endpoint over available therapies." In plain English, NightWare might very well become the first
prescribable digital therapeutic for a key symptom of PTSD. It's a big deal coming to an Apple Watch near you.

                                                                                                      Page 4 of 18
                     Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference

4. Eyesafe (Eden Prairie, Minnesota); Capital Raised: $9 Million

Projecting Apple's resurgence and ultimate market dominance in consumer tech, years before the iPhone, made
tech-watcher Gene Munster something of an oracle on Wall Street. Now a founding partner at tech-focused VC
Loup Ventures, Munster has become a regular fixture on the business news circuit as he shares his hot takes on
Tesla, Apple, Amazon and the tech industry at large. Munster believes            Eyesafe, a privately held company
that is advancing consumer electronics with its blue light protection technology, has become an influential player,
building standards for safeguarding users' eyes from the intense, albeit invisible, blue light that Harvard Medical
School says "       has a dark side."

"I don't have a financial stake directly or indirectly in Eyesafe," cautioned Munster. "But brands like Dell, HP and
Lenovo are becoming increasingly aware of the health dangers posed by blue light. Eyesafe sits atop a very short
list of solutions that large tech companies are turning to for help in designing and implementing safer displays that
maintain color performance. While nascent today, Eyesafe's long-term addressable market is significant, given that
over time, some form of blue light protections will likely be mandated in all displays."

In fact, Eyesafe has already cut impressive deals with Dell and aftermarket screen-protector leader ZAGG,
distributed in Verizon, AT&T and T-Mobile stores across the nation, as well the major component suppliers in the
electronics industry. And with the passage of the State of California's recent "Blue Light Resolution," it seems
Munster's prediction of regulation is happening fast, putting Eyesafe in pole position to own the low blue light
market and, in the process, seize the mantle as the "          Intel Inside" of health and safety across consumer
electronics.

5. MyMeds (Minneapolis, Minnesota); Capital Raised: $8 Million

Your doctor prescribes some medication and tells you to pick it up at the local pharmacy. Once you show up at the
Duane Reade or CVS, an officious-looking individual in a white lab coat gives you a brief glimpse of an amber
colored pill container, mumbles a word or two of advice and then places your prescription in a white bag, along with
an intimidating piece of paper full of fine print, sending you on your way. Now, you are on your own; it's just you, a
dozen or so pills, and a piece of paper written by a lawyer who went to medical school, or maybe the other way
around.

Sound familiar? Today's medication experience is broken, and with the phenomenon of medication non-adherence
emerging as the biggest issue driving up health care costs across the entire sector, MyMeds is bringing to market a
suite of solutions unlike any other in the digital health space.

"We are redefining the medication experience so people are never alone and always have access to their own
data," said MyMeds founder and CEO Dr. Rajiv Shah, whose company was recently selected to join SAP's
prestigious accelerator program in New York City. "Our patented Digital + Human ACE Medication Experience is an
ecosystem that connects patients, caregivers, providers and payors in real-time." In more plain speak, Shah's
MyMeds is laying pipe that connects doctor, pharmacist, you and your health insurance in ways that have never
been possible before, savings costs and ensuring better health outcomes.

The experts Observer spoke to believe that 2020 will be a breakout year for MyMeds, as it rolls out its integration
with SAP, launches a new real-time Medicare Stars product and unfurls the much-anticipated MyMeds
Connect(TM), a secure real-time prescription data connectivity engine-a real game changer in light of Washington's
focus on medication history data rights. According to Fox Business Network analyst Ethan Bearman, who follows
the booming medication non-adherence space, MyMeds has the potential to become a billion-dollar company in the
coming years.

"Some health companies are really smart with their tech or business model, while others are just plain lucky in that
the regulatory environment sways in their direction at just the right time," Bearman told Observer. "MyMeds is both
smart and lucky, which is why it wouldn't surprise me if Dr. Raj is able to launch his own version of Tres Comas
Tequila sometime in the next few years."

                                                                                                       Page 5 of 18
                     Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference

6. Regroup + InSight (Chicago, Illinois); Capital Raised: $19 Million + Undisclosed Private Equity Backing

While it may be unorthodox for two companies to be named in one spot, a recent merger between Regroup
Telehealth and InSight Telepsychiatry deserves the spotlight. The two companies merged in late 2019, and the
combined company is now packing a lot of heat, making it one of the largest and most comprehensive
telepsychiatry service providers in the U.S. The new entity is tackling mental health care disparities head on with
their unique suite of individualized telehealth services.

Many times, being geographically, economically or socially isolated means that patients with mental health issues
don't have access to the specialized psychiatric care that they require. Regroup + Insight is connecting patients
from one end of the country to the doctors and specialists they need to see, irrespective of their physical location.
With a high-capacity data pipe from the physicians' location to the clinical setting, the Regroup + Insight tie-up
enables doctors to treat, consult and prescribe medication from afar and coordinate remotely with the patient's local
health care support team.

Like several other companies on both this year's and last year's lists, Regroup was born inside of Chicago's Health
Incubator, Matter, which has emerged as a breeding ground for some of the most innovative and fast-growing
companies in digital health. Now all their C-Suite needs to do is come up with a name for the new combined entity.

7. Revel Health (Minneapolis, Minnesota); Capital Raised: $17 Million

Revel Health is rewriting the playbook for how health plans talk to their members. Gone are the days of the
robocall with a voice that sounds entirely too enthusiastic reminding you that it's time for another prostate exam or a
mailed form letter that looks like an audit notice from the IRS reminding you that it is flu-shot season.

After initially catching Observer's eye late last year, the experts we spoke to were impressed with not only the
company's tech, but also its savvy application into real-world, actionable results. Revel uses lessons that consumer
marketers and Big Retail pioneered and is applying them across the health care marketplace. Revel helps
members stay healthier by connecting them with their health care support system through sophisticated AI, which
culls and analyzes mind-boggling Big Data sets and translates them into personable and highly personalized health
action communication. Under the leadership of veteran health care CEO Jeff Fritz, Revel is leading a revolution in
preventive health care and is quickly becoming a secret weapon for major health plans.

8. Owlet (Lehi, Utah); Capital Raised: $48 Million

Perhaps it isn't a coincidence that Utah-based Owlet Baby Care was started in the same state that has the largest
average household size in the U.S. Or maybe the team at Owlet just knows how hard it is raising a child, much less
two or three, which is why they are betting big that over-protective parents want more than a simple nanny cam to
keep an eye on their brood.

Owlet is gaining traction with a product set that provides parents with real-time, non-invasive video and audio
monitoring, allowing for the child's blood oxygen level, heart rate, temperature and sleeping patterns to be
monitored and tracked by an app easily accessible on any worried parent's smartphone. Founded by a team of
passionate parents in 2013, this Silicon Slopes company is taking the baby monitoring game to an entirely new
level and investors love it.

The company's newest innovation, the Owlet Band Pregnancy Monitor, is on track to be the hottest product in baby-
care tech this year, having already won two distinctive awards at the Consumer Electronics Show for Best
Wearable and Tech to Change the World.

9. PhysIQ (Chicago, Illinois); Capital Raised: $25 Million

PhysIQ can detect the smallest, most subtle changes in an individual's biosensory data and can alert care teams to
potential problems far before they would surface during a regular check-up. The technology enables doctors to see
around corners by applying sophisticated, FDA-cleared physiological analytics to extract personalized health

                                                                                                         Page 6 of 18
                      Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference

insights. This Windy City startup uses software that was originally designed for data-tracking on jet engines and
nuclear power plants, where the smallest performance deviations can pose immensely profound dangers. Now,
PhysIQ is taking that same approach to performance calibration and applying it to the human body; it tracks data
around the clock to capture a patient's standard bodily rhythms and tempos and packages the data into neat,
digestible bundles for clinical teams all around the country. Like several other entries on this year's list, PhysIQ is a
product of downtown Chicago's Matter health incubator.

10. Pops! Diabetes (Oak Park Heights, Minnesota); Capital Raised: $8 Million

Siri and Alexa: Meet Mina-every diabetics' new best friend and one of the latest products from Minnesota-based
Pops! Diabetes, a company which is upending the consumer side of the nearly $200 billion global diabetes market.
CEO Lonny Stormo believes that while self-care should take precedence, life oftentimes gets in the way, which is
why his consumer-first approach to diabetes management has focused on platforms such as Mina that can step in
and do important monitoring on a patient's behalf. "Mina sent an alert to my wife when my blood-sugar read 60. She
was able to get in touch with me and my doctor immediately and make sure we addressed the situation promptly,"
Stormo recounted to Observer. "Mina really helps me own my diabetes, and not let the diabetes own me."

Mina is a state-of-the-art chronic care management platform that tracks health management for diabetics and its
always on; cloud-based accessibility means that an individual's care support team, from loved ones to doctors, can
be instantly alerted about a potential crisis by receiving an alert from Mina.

Simplifying the diabetes management business is a huge area of focus for both medtech and health care.

Stormo, a Medtronic alum, will be kicking off a new round of capital raising at this year's J.P. Morgan Healthcare
Conference, and his dance card is filling up quickly. "We have been fortunate to be coming to market just as the
interest in virtual care and diabetes management is near or at the top of the shopping list of many digital health
VCs," offered Stormo.

11. DispatchHealth (Denver, Colorado); Capital Raised: $68 Million

They seem like genius ideas: Need a ride? Hail an Uber. Hungry? Ping GrubHub. But what about if you need a
doctor? Colorado-based DispatchHealth is proving that with technology, on-demand health care at your doorstep is
not only possible, but also a viable business model. In a few taps, via the Disptach app, a board-certified medical
team will come to your home, office or wherever you need them to be, equipped with all the tools necessary to
tackle whatever specialized care you might need.

As access to medical care becomes increasingly consumer-focused, it seems that many health tech investors
believe that visits to traditional brick-and-mortar health care facilities will be reserved only for the most serious of
situations.

12. Learn to Live (Minneapolis,Minnesota); Capital Raised: $9 Million

There is no shortage of well-funded startups looking to stake out their own territory in the red-hot digital mental
health therapy space. Health plans, large employers and universities, governments and branches of the military, as
well as the VA, among many others, are keen to offer online CBT (cognitive behavioral therapy) to their members,
students and employees.

In a recent Observer profile of the digital mental health space, Learn to Live was highlighted as one of the
innovators in the sector, pushing the industry to adopt more serious, evidenced-based approaches to digital mental
health treatment in contrast to many of its competitors, which, despite having raised significant amounts of capital,
seem to be dabbling in what can best be described as different flavors of "pop psychology." 2019 was a banner
year for Minneapolis-based Learn to Live, inking scores of key new accounts, including a collaboration with
Blue Cross Blue Shield of Massachusetts, as well as landing a coveted billing in Express Scripts'             Digital
Health Formulary.

                                                                                                       Page 7 of 18
                     Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference

Learn to Live's co-founder and CEO Dale Cook grew up in Bogot√°, Colombia, the son of missionaries, and the first-
time entrepreneur has certainly infused Learn to Live with a sense of mission and purpose. The company recently
announced the launch a new product tackling substance use, which makes it among the first to market to address
this clinical need.

13. Lifesprk (St. Louis Park, Minnesota); Capital Raised: $36 Million

Senior or geriatric care is among the fastest growing segments in health care. The nearly $740 billion elderly-care
market is ripe for disruption, and Minnesota-based Lifesprk has adroitly carved out a commanding position to
capitalize on this burgeoning segment of the health care landscape. At its core, Lifesprk is all about bringing a
comprehensive suite of support services to elderly patients, empowering them and their families to stay in control
and enabling them to live the life they want and to retire on their own terms. But behind the scenes-and this is why
founder and CEO Joel Theisen has become something of a superstar within the national senior care marketplace-is
the data.

Lifesprk is collecting and integrating data that has either been siloed, or not even captured at all, to develop a
personalized Electronic Life Record, or ELR, an innovative platform that is as revolutionary to senior care as the
Bloomberg Terminal was to global financial markets. By aggregating huge data sets focused on the individual,
Lifesprk can quickly identify and even suggest personalized services at the appropriate price point to meet the
needs any life scenario a senior might encounter. The result is longer, fuller lives, lower costs and a booming
company.

14. IDx (Iowa City, Iowa); Capital Raised: $55 Million

The eyes are all-important gateway into our mind, body and, some might say, soul. IDx's flagship product, the IDx-
DR, is the first FDA-approved autonomous artificial intelligence (AI) platform that uses software to analyze images
from a high powered camera for evidence of retinal lesions typically associated with the early onset of blindness
from diabetes. Founded by an ophthalmologist originally from the Netherlands who moved to the Midwest to
practice medicine at the University of Iowa, this startup is revolutionizing the early detection of blindness, a common
affliction associated with diabetes, which afflicts roughly 8.5% of the global population.

The company's secret sauce is its ability to scale by sidestepping the need for a clinician to interpret the results of
its retinal scans, making the data more widely available by health care providers who are not normally involved in
eye care.

15. Sera Prognostics (Salt Lake City, Utah); Capital Raised: $151 million

Mothers-to-be and physicians are increasingly turning to Utah-based Sera Prognostics for early prediction of a
woman's individualized risk of premature birth and other pregnancy-related complications. The company is a real
game changer, having developed a suite of diagnostic tests designed to give women and their physicians the time
needed to make individualized treatment and care plans. The company's flagship product, the PreTRM blood test,
is the only clinically recognized bio-marker available to the public at large.

Dr. Garrett Lam, Sera's chief medical officer, commented, "I've shared in the heartbreak and tragedy caused by
complications of pregnancy throughout my career. Our work at Sera, to identify risks early in pregnancy, will assist
doctors, positively impact mothers and benefit the health of newborns to make a significant difference in our
world."

The health care investment community is betting big on Sera becoming the gold-standard for early-risk detection in
expectant mothers and a global leader in high-value women's health diagnostics. Like many other entries on this
year's list, Sera is solving a specific set of issues-in this case, by delivering pivotal information to patients and
physicians-that will play a broader role in improving the economics of the entire health care ecosystem.

16. Aunt Bertha (Austin, Texas); Capital Raised: $22 Million

                                                                                                        Page 8 of 18
                     Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference

In the U.S., there are thousands of nonprofits and social care providers set up to serve those in need, but the reality
is that navigating the complex maze of which organization does what is nothing short of daunting for the average
person in need. For many, what should be a simple and straightforward process, becomes time consuming, leaving
many frustrated to the point of giving up. Bottomline: too many Americans are needlessly suffering despite a surfeit
of accessible resources from charities, NGOs and nonprofits. Enter Aunt Bertha, an Austin-based platform that
connects people seeking help and the verified social care providers that serve them. Aunt Bertha is the "favorite
Aunt you can trust," powering the country's most comprehensive online directory of social service organizations.

But Aunt Bertha is more than just a 'Yellow Pages' for social services; the reason the company has become a
favorite among VCs is its ability to tap into a largely overlooked, but critically important, aspect of the health care
ecosystem, offering big brand health care customers solutions with advanced features like EHR (Electronic
Hospital Record) integrations and giving caregiver teams a more complete view of a patient's global support
environment.

17. AxialHealthcare (Nashville, Tennessee); Capital Raised: $26 Million

Presidential candidates on the campaign trail often talk about the nation's runaway opioid epidemic. According to
the 2018 National Survey on Drug Use and Health, over 10 million Americans aged 12 and older misused opioids
in 2018, and the impact on communities across the country has been devastating. Nashville-based AxialHealthcare
is teaming up with hospitals and caretakers around the country to combat opioid abuse by leveraging state-of-the
art analytics to identify patients at risk, prevent escalation of their conditions and support appropriate treatment
enrollment and adherence. Axial is on the frontline of a deadly diseases (nearly 130 Americans die each day from
opioid-related abuse) and an immense marketplace; last year, over $200 billion was spent combating the opioid
epidemic in the U.S.

Axial's approach is predicated on a high-touch, community-based approach that delivers clinical metrics and
financial outcomes by managing the cost of care while supporting sustained recovery efforts for patients diagnosed
with opioid use disorder. Newly-minted CEO Carter Paine-the former president and COO of value-based care
manager naviHealth, who brings a career's worth of insight from his time working with companies in the IT and
health services world-will look to expand the Axial platform's reach, which now covers nearly three million people.

18. Benovate (Minneapolis, Minnesota); Capital Raised: $6 Million

Although no one can find the original tape recording, the quote, "Let food be thy medicine, and let medicine be thy
food" is famously attributed to the ancient Greek physician Hippocrates-often regarded as the father of all medicine.
Whether Hippocrates actually said it or not, it's increasingly clear that our less than ideal 21st century diets are the
root cause behind a host of modern health issues, and Benovate is one of the leading disruptors in the "food as
medicine" movement, mixing up an elixir of tech, AI, nutrition and health care industry knowledge to market their
trademarked Gx product (a riff off the pharmaceutical 'Rx' with 'G' for grocery).

Benovate is wellbeing 2.0. Its Gx app is breaking new ground in enabling the entire health ecosystem, from doctor
to insurance provider, to prescribe and reimburse everyday foods, like a cucumber, which is packed with valuable
nutrients. Under the seasoned guidance of company CEO Mark Walinske, a 30-year veteran of the health care
space, Benovate's Gx product aims to transform your local grocery into the neighborhood pharmacist.

19. Abilitech Medical (St. Paul, Minnesota); Capital Raised: $9 Million

Fresh off a $7.4 Million Series A financing round, Minnesota's Abilitech Medical has a gust of arctic wind at its back.
CEO Angie Conley has collected so many business awards in the last year that she is probably running out of room
atop her fireplace mantle. And that's a good thing because Abilitech is a company with a lot of heart in addition to
solving a very serious health challenge-enabling those with upper-limb neuromuscular conditions to function
independently.

                                                                                                      Page 9 of 18
                     Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference

The company's first product, the Abilitech Assist, is a powered orthotic device providing functional assistance and
support to both the elbow and the shoulder, improving the lives of those affected by muscular dystrophy, multiple
sclerosis, spinal cord injury and, in some cases, those who have suffered a stroke.

In 2020, the company is poised to earn FDA registration, undergo clinical studies and begin widespread
commercialization of the Abilitech(TM) Assist, which has made many VCs at this year's confab in San Francisco
eager to get some quality time with Conley. Observer isn't the only publication to have realized the potential of this
game-changing company; they've already received recognition as a Top 10 Medical Device Startup in the country
by Medical Tech Outlook magazine, a Top 10 Promising Company by the Rice Alliance, and was touted as a Top
20 Medical Device Startup by MassDevice.

20. Omcare (Bloomington, Minnesota); Capital Raised: $9 Million

What's the size of breadbox, looks like a coffee-maker designed by Apple and dispenses pills? No idea? It's the
Omcare home medicine dispenser, equipped with a pair of Wi-Fi-enabled interactive cameras that will enable
caregivers to watch grandma in real-time not only handle the packet of pre-loaded pills (at the right time), but also
swallow them as well (ergo the second camera!) to ensure there is none of that "hide the pill under the tongue
trickery." The Omcare technology, which was adapted from founder and CEO Lisa Lavin's previous intelligent treat
dispenser for pets startup, has a deadly serious mission: reduce errors in medication and maximize adherence in
the elderly community.

Omcare was recently given a big boost by the addition of long-time health care veteran Jeannine Rivet to its board.
Rivet, the former executive vice president of UnitedHealth Group, one of the world's largest publicly-traded health
care corporations, believes that remote care is the way of the future and that companies like Omcare, which enable
elderly patients to stay independent longer, make sense not only in terms of the economics, but also by meeting the
needs of seniors who desire to age in place.

"I began my career in health care as a nurse, and so I know first-hand the challenges and constraints placed upon
caregivers," Rivet explained. "Although in its early stages, Omcare has the potential to revolutionize medication
non-adherence among elderly and others struggling to manage chronic or complex health conditions."

Omcare's Home Health Hub utilizes audio and visual messages, which lets caregivers and care teams monitor
medication adherence, and its multi-dose packaging is specially designed in collaboration with pharmacies so that
correct dosage consumption is no longer an issue.

Finding Diamonds in the Rough

The annual J.P. Morgan Healthcare Conference sets the tone for the rest of the year when it comes to the biggest
trends crisscrossing the global health care industry. Last year, the surfeit of bold health care innovators emerging
from places like St Louis, Missouri and Columbus, Ohio, for example, wasn't a surprise to industry insiders, but it
did appear to catch some of the coastal business media who only breathe in that rarified air of Silicon Valley
somewhat by surprise. But this year, VCs, Big Pharma, big health care and the business media are well aware that
some of the biggest stars at this year's conference will hail from 'flyover country.'

Aly Lovett, a partner at New York City-based Radian Capital, a growth equity firm with a strong presence in the
health care software space, openly embraces looking for investment opportunities in cities typically overlooked by
most traditional health care VCs. "The knowledge base required to build a leading technology company is no
longer concentrated in just a few cities, and capital is starting to follow that trend. Lower costs, higher quality of
living and more diffused access to great talent make these smaller cities highly desirable places to start
businesses," commented Lovett. "There are many amazing angels and seed funds in these regions that can help
get companies started, and we think there is an opportunity for Radian to provide growth equity to support these
businesses in their next phase of growth."

                                                                                                          Page 10 of 18
                      Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference

But if Lovett has been holding on to something of a secret, it would seem that her secret is now out in the open;
capital far and wide is searching for the new, new thing in health tech from flyover country, and many will be using
the J.P. Morgan confab as an opportunity to get to know them.

No matter where they call home.

On Monday, January 13, like a swarm of honey bees, thousands of health tech entrepreneurs, health care execs,
venture capitalists, bankers, regulators and business media will descend upon downtown San Francisco as the 38th
Annual J.P. Morgan Healthcare Conference gets under way. And, as is the case with any multi-day industry
gathering worth its salt, an entire ecosystem of satellite events has popped up around the main attraction, which
has created a seemingly endless circuit of networking events, summits and other health care-related shindigs-all
offering ample excuses to down lattes during the day and throw back a shot or two at night.

Even though only a select few are invited to attend the official main stage, marking one's presence at J.P. Morgan
is paramount, as the four-day confab has positioned itself as not only the first, but perhaps the most important event
of the global health care conference calendar year.

SEE ALSO: Revel Is Rewriting the Playbook on How Health Plans Talk to You

Ahead of last year's J.P. Morgan gathering, Observer was among the first to point out a trend that was beginning to
emerge across the health industry-the rise in interest from both large health care players, as well as hungry
venture capitalists, for health tech plays originating in cities not typically associated with startup culture, places like
Minneapolis, Nashville and Chicago. Observer even coined a new term for these disruptors from Middle America:
Flyover Tech.

And, judging by the pre-conference buzz, by all accounts, last year was not a fluke; many of the entries from the
2019 list have emerged as some of the biggest and most important players in their respective sectors over the past
12 months. Some of them have even carved out completely new niches within the vast health care ecosystem that
didn't exist a year ago.

As some informed observers of the high-flying health tech space quipped, "Flannel is the New Black," when it
comes to innovation in health care and big bets in health tech.

Take for example Bind, a Minneapolis-based startup health plan that has already raised a jaw-dropping $82 million.
After occupying last year's top position on the list for its ability to use data science and artificial intelligence (AI) to
analyze existing claims data, Bind had a banner year. The company has been expanding its services across
multiple new areas of coverage, while empowering customers to understand what they are really paying for with
their health plans, which makes it easy to compare treatment options, prices and quality. Bind, along with fellow
Minnesota wunderkind health insurance startup                 Bright Health-which just announced the closing of
$635 million in Series D financing in December, on top of over $400 million of funding in previous rounds (putting its
total raise now over the billion dollar mark)-have chiseled out completely new offerings in the health insurance
space, a sector that, less than a decade ago, was considered nearly impenetrable due to the vast resources
needed to scale a business of that nature.

"It still amazes me the number of investors that haven't taken full advantage of the 'flyover tech' ecosystem,"
observed Jodi Hubler, managing director of Lemhi Ventures, a venture capital firm that invests primarily in early- to
mid-stage health companies in the Midwest and Rocky Mountain regions. "Many places in Middle America are
actually centers of innovation and deep domain knowledge not only in health care, but in medtech device and
services as well," added Hubler, referring to the largest players in health care and medtech, like UnitedHealth
Group, Medtronic, Cardinal Health, Humana and Anthem-all of which have main bases of operations in between
the coasts.

"It's common sense economics-every dollar of capital goes further in these locations, and the access to talent from
developers to board members comes with differentiated experience and knowledge," Hubler told Observer. "In

                                                                                                     Page 11 of 18
                     Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference

places like the Midwest, people don't play in health care, they've lived it... that experience and intuition is
invaluable."

Another big winner from last year's list was Nashville-based SmileDirectClub, a tele-dentistry startup that produces
direct-to-consumer 3D-printed clear aligners. In September, the teeth-straightening startup went public,
raising more than $1.3 billion at an initial market cap of roughly $10 billion, more than three times its most recent
private valuation. And although the stock price has since clawed back some of those ebullient IPO gains, it's yet
another shining example of a flyover tech success story.

Flyover Tech Is Now a 'Badge of Honor' in Health Tech

For serial health care entrepreneur and founder of San Francisco-based Roam Analytics Alex Turkeltaub, there is
gold to be mined in Middle America. "Hubs like Raleigh, Columbus and Nashville, just to name a few, are quickly
becoming known as exciting centers of innovation in health care. With strong legacy technology and health care
systems, it's only natural that these local ecosystems will fuel the next generation of disruptors in digital health,"
observed Turkeltaub, who recently stepped down as CEO of Roam and is setting up a venture fund that focuses on
the         intersection of AI and health care. The fund will look to make strategic investments in major health tech
hubs across the country, as well as in emerging overseas markets like Brazil.

"The term 'flyover' used to be somewhat derogatory, but now it's a badge of honor in health tech. Entrepreneurs in
the middle of the country know that technology can't exist for its own sake; it has to be combined with functional
business models to deliver real value to patients and investors alike," added Turkeltaub. "Any serious health care
VC who isn't making monthly visits to places like Minneapolis or Chicago is completely missing the boat."

Chicago, Nashville and Minneapolis Are Emerging as the New 'Silicon Valleys' of Health Tech

Although there are entries on this year's list from a wide swath of cities across the country, experts and insiders
repeatedly point to the surfeit of companies emerging from three major hubs of innovation in health care from
Middle America: Nashville, Chicago and the Twin Cities of Minneapolis and St. Paul.

"With a diverse set of headquartered legacy companies spanning the entire spectrum of health care, regional hubs
such as Nashville, Chicago and Minneapolis will continue to produce industry-leading innovation and transformation
in the sector. These are the new hotbeds in health care," noted Sara Ratner, a veteran health care industry insider
who is one of the nation's foremost experts on government-run Medicare and Medicaid programs.

Observer spoke with health care experts from across the U.S. to offer their thoughts about the biggest emerging
trends at the 2020 J.P. Morgan Healthcare Conference and the sector's continued interest in flyover tech. They
were also asked to highlight some of the hottest companies in between the two coasts that will be feted in San
Francisco this week. Like last year, the current list is not a ranking in the traditional sense-the companies singled
out are in different stages of development and growth and, for the most part, are positioned in non-competing
verticals; rather, the list is a snapshot of 20 early- to mid-stage startups that have caught the attention of health
care insiders from around the globe and have one thing in common: they all hail from what many a New Yorker
might describe as 'flyover country.'

And now, here is Observer's 20 Hottest Companies in 'Flyover Tech' at the 2020 J.P. Morgan Healthcare
Conference.

1. HistoSonics (Ann Arbor, Michigan); Capital Raised: $87 Million

Non-invasive cancer treatment. Let those words sink in. By using technology similar to an ultrasound, this new
interventional therapy will transform nearly all forms of cancer detection and eradication. In some respects, the
company's flagship product is not unlike the "healing machine"-the technology central to the plot to the 2013 Matt
Damon thriller Elysium set 134 years in the future.

                                                                                                      Page 12 of 18
                     Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference

Led by veteran health care executive Mike Blue, the company's non-invasive robotics platform and novel sonic
beam therapy is awaiting full FDA clearance, but the company has already announced reams of promising new
clinical and preclinical data, including successful human trials in Spain. In April of last year, HistoSonics closed a
$54 million C-Round led by Varian Medical Systems, Inc., the global leader in radiation therapy and oncology
solutions, and included          Johnson & Johnson Innovation and the          State of Wisconsin Investment Board,
among others. Initially targeting liver and pancreatic cancer, HistoSonics' Robotically Assisted Sonic Therapy
(RASTSM) combines advanced robotics and imaging with a proprietary sensing technology to deliver personalized
treatments with unparalleled precision and control. In layman's terms, the tech uses sound energy to generate
pressures strong enough to liquify and completely destroy targeted tissues at sub-cellular levels.

Meanwhile, HistoSonics is busy building a new HQ in a Minneapolis suburb. "Our tech was born in the labs of the
University of Michigan, but we quickly realized we needed to be at the epicenter of health care innovation, which is
why we decided to move our base to Minnesota," explained Blue. "This is where all the action is right now in health
tech."

2. Olive AI (Columbus, Ohio); Capital Raised: $72.8 Million

Over one trillion dollars are spent every year in the U.S. on health care administration. Not on doctors, needles,
meds or IVs, but on pens, paper, IT and something called 'system integration.' It's a huge outlay-and the fact that
much of that spend could be better directed toward treating patients and saving lives is what constitutes the driving
force behind Ohio-based startup Olive AI.

CEO Sean Lane and the team at Olive understand that hospital employee time is money, which is why in the last
year, their AI-powered workforce has become the utility player for over 500 individual hospitals around the U.S.,
handling high-volume, administrative workloads. Olive's automated workforce takes on the minutia of the often
repetitive paperwork that plagues nearly all sectors of health care-from human resources and IT to supply chain
management and revenue cycle tracking-allowing employees to focus on the important, big picture aspects of their
work. Convenient, efficient, fast and accurate, Olive AI is an overworked employee's dream assistant, and the
venture world, which has plowed over $70 million into the company thus far, seems to agree.

3. NightWare (Minneapolis, Minnesota); Capital Raised: Undisclosed

The highly secretive NightWare was on last year's hot list, and while it is still not disclosing its fundraising totals
(one of the advantages of not raising with institutional investors), the company continues to make big strides in the
treatment of PTSD and nightmare disorder, a condition affecting over five million Americans and hundreds of
thousands of U.S. vets. Over the past 12 months, NightWare received official "Breakthrough Status" designation by
the FDA, which is only given to treatments that, according to the FDA, "demonstrate substantial improvement on a
clinically significant endpoint over available therapies." In plain English, NightWare might very well become the first
prescribable digital therapeutic for a key symptom of PTSD. It's a big deal coming to an Apple Watch near you.

4. Eyesafe (Eden Prairie, Minnesota); Capital Raised: $9 Million

Projecting Apple's resurgence and ultimate market dominance in consumer tech, years before the iPhone, made
tech-watcher Gene Munster something of an oracle on Wall Street. Now a founding partner at tech-focused VC
Loup Ventures, Munster has become a regular fixture on the business news circuit as he shares his hot takes on
Tesla, Apple, Amazon and the tech industry at large. Munster believes            Eyesafe, a privately held company
that is advancing consumer electronics with its blue light protection technology, has become an influential player,
building standards for safeguarding users' eyes from the intense, albeit invisible, blue light that Harvard Medical
School says "       has a dark side."

"I don't have a financial stake directly or indirectly in Eyesafe," cautioned Munster. "But brands like Dell, HP and
Lenovo are becoming increasingly aware of the health dangers posed by blue light. Eyesafe sits atop a very short
list of solutions that large tech companies are turning to for help in designing and implementing safer displays that

                                                                                                     Page 13 of 18
                     Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference

maintain color performance. While nascent today, Eyesafe's long-term addressable market is significant, given that
over time, some form of blue light protections will likely be mandated in all displays."

In fact, Eyesafe has already cut impressive deals with Dell and aftermarket screen-protector leader ZAGG,
distributed in Verizon, AT&T and T-Mobile stores across the nation, as well the major component suppliers in the
electronics industry. And with the passage of the State of California's recent "Blue Light Resolution," it seems
Munster's prediction of regulation is happening fast, putting Eyesafe in pole position to own the low blue light
market and, in the process, seize the mantle as the "          Intel Inside" of health and safety across consumer
electronics.

5. MyMeds (Minneapolis, Minnesota); Capital Raised: $8 Million

Your doctor prescribes some medication and tells you to pick it up at the local pharmacy. Once you show up at the
Duane Reade or CVS, an officious-looking individual in a white lab coat gives you a brief glimpse of an amber
colored pill container, mumbles a word or two of advice and then places your prescription in a white bag, along with
an intimidating piece of paper full of fine print, sending you on your way. Now, you are on your own; it's just you, a
dozen or so pills, and a piece of paper written by a lawyer who went to medical school, or maybe the other way
around.

Sound familiar? Today's medication experience is broken, and with the phenomenon of medication non-adherence
emerging as the biggest issue driving up health care costs across the entire sector, MyMeds is bringing to market a
suite of solutions unlike any other in the digital health space.

"We are redefining the medication experience so people are never alone and always have access to their own
data," said MyMeds founder and CEO Dr. Rajiv Shah, whose company was recently selected to join SAP's
prestigious accelerator program in New York City. "Our patented Digital + Human ACE Medication Experience is an
ecosystem that connects patients, caregivers, providers and payors in real-time." In more plain speak, Shah's
MyMeds is laying pipe that connects doctor, pharmacist, you and your health insurance in ways that have never
been possible before, savings costs and ensuring better health outcomes.

The experts Observer spoke to believe that 2020 will be a breakout year for MyMeds, as it rolls out its integration
with SAP, launches a new real-time Medicare Stars product and unfurls the much-anticipated MyMeds Connect, a
secure real-time prescription data connectivity engine-a real game changer in light of Washington's focus on
medication history data rights. According to Fox Business Network analyst Ethan Bearman, who follows the
booming medication non-adherence space, MyMeds has the potential to become a billion-dollar company in the
coming years.

"Some health companies are really smart with their tech or business model, while others are just plain lucky in that
the regulatory environment sways in their direction at just the right time," Bearman told Observer. "MyMeds is both
smart and lucky, which is why it wouldn't surprise me if Dr. Raj is able to launch his own version of Tres Comas
Tequila sometime in the next few years."

6. Regroup + InSight (Chicago, Illinois); Capital Raised: $19 Million + Undisclosed Private Equity Backing

While it may be unorthodox for two companies to be named in one spot, a recent merger between Regroup
Telehealth and InSight Telepsychiatry deserves the spotlight. The two companies merged in late 2019, and the
combined company is now packing a lot of heat, making it one of the largest and most comprehensive
telepsychiatry service providers in the U.S. The new entity is tackling mental health care disparities head on with
their unique suite of individualized telehealth services.

Many times, being geographically, economically or socially isolated means that patients with mental health issues
don't have access to the specialized psychiatric care that they require. Regroup + Insight is connecting patients
from one end of the country to the doctors and specialists they need to see, irrespective of their physical location.
With a high-capacity data pipe from the physicians' location to the clinical setting, the Regroup + Insight tie-up

                                                                                                        Page 14 of 18
                      Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference

enables doctors to treat, consult and prescribe medication from afar and coordinate remotely with the patient's local
health care support team.

Like several other companies on both this year's and last year's lists, Regroup was born inside of Chicago's Health
Incubator, Matter, which has emerged as a breeding ground for some of the most innovative and fast-growing
companies in digital health. Now all their C-Suite needs to do is come up with a name for the new combined entity.

7. Revel Health (Minneapolis, Minnesota); Capital Raised: $17 Million

Revel Health is rewriting the playbook for how health plans talk to their members. Gone are the days of the
robocall with a voice that sounds entirely too enthusiastic reminding you that it's time for another prostate exam or a
mailed form letter that looks like an audit notice from the IRS reminding you that it is flu-shot season.

After initially catching Observer's eye late last year, the experts we spoke to were impressed with not only the
company's tech, but also its savvy application into real-world, actionable results. Revel uses lessons that consumer
marketers and Big Retail pioneered and is applying them across the health care marketplace. Revel helps
members stay healthier by connecting them with their health care support system through sophisticated AI, which
culls and analyzes mind-boggling Big Data sets and translates them into personable and highly personalized health
action communication. Under the leadership of veteran health care CEO Jeff Fritz, Revel is leading a revolution in
preventive health care and is quickly becoming a secret weapon for major health plans.

8. Owlet (Lehi, Utah); Capital Raised: $48 Million

Perhaps it isn't a coincidence that Utah-based Owlet Baby Care was started in the same state that has the largest
average household size in the U.S. Or maybe the team at Owlet just knows how hard it is raising a child, much less
two or three, which is why they are betting big that over-protective parents want more than a simple nanny cam to
keep an eye on their brood.

Owlet is gaining traction with a product set that provides parents with real-time, non-invasive video and audio
monitoring, allowing for the child's blood oxygen level, heart rate, temperature and sleeping patterns to be
monitored and tracked by an app easily accessible on any worried parent's smartphone. Founded by a team of
passionate parents in 2013, this Silicon Slopes company is taking the baby monitoring game to an entirely new
level and investors love it.

The company's newest innovation, the Owlet Band Pregnancy Monitor, is on track to be the hottest product in baby-
care tech this year, having already won two distinctive awards at the Consumer Electronics Show for Best
Wearable and Tech to Change the World.

9. PhysIQ (Chicago, Illinois); Capital Raised: $25 Million

PhysIQ can detect the smallest, most subtle changes in an individual's biosensory data and can alert care teams to
potential problems far before they would surface during a regular check-up. The technology enables doctors to see
around corners by applying sophisticated, FDA-cleared physiological analytics to extract personalized health
insights. This Windy City startup uses software that was originally designed for data-tracking on jet engines and
nuclear power plants, where the smallest performance deviations can pose immensely profound dangers. Now,
PhysIQ is taking that same approach to performance calibration and applying it to the human body; it tracks data
around the clock to capture a patient's standard bodily rhythms and tempos and packages the data into neat,
digestible bundles for clinical teams all around the country. Like several other entries on this year's list, PhysIQ is a
product of downtown Chicago's Matter health incubator.

10. Pops! Diabetes (Oak Park Heights, Minnesota); Capital Raised: $8 Million

Siri and Alexa: Meet Mina-every diabetics' new best friend and one of the latest products from Minnesota-based
Pops! Diabetes, a company which is upending the consumer side of the nearly $200 billion global diabetes market.
CEO Lonny Stormo believes that while self-care should take precedence, life oftentimes gets in the way, which is

                                                                                                       Page 15 of 18
                     Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference

why his consumer-first approach to diabetes management has focused on platforms such as Mina that can step in
and do important monitoring on a patient's behalf. "Mina sent an alert to my wife when my blood-sugar read 60. She
was able to get in touch with me and my doctor immediately and make sure we addressed the situation promptly,"
Stormo recounted to Observer. "Mina really helps me own my diabetes, and not let the diabetes own me."

Mina is a state-of-the-art chronic care management platform that tracks health management for diabetics and its
always on; cloud-based accessibility means that an individual's care support team, from loved ones to doctors, can
be instantly alerted about a potential crisis by receiving an alert from Mina.

Simplifying the diabetes management business is a huge area of focus for both medtech and health care.

Stormo, a Medtronic alum, will be kicking off a new round of capital raising at this year's J.P. Morgan Healthcare
Conference, and his dance card is filling up quickly. "We have been fortunate to be coming to market just as the
interest in virtual care and diabetes management is near or at the top of the shopping list of many digital health
VCs," offered Stormo.

11. DispatchHealth (Denver, Colorado); Capital Raised: $68 Million

They seem like genius ideas: Need a ride? Hail an Uber. Hungry? Ping GrubHub. But what about if you need a
doctor? Colorado-based DispatchHealth is proving that with technology, on-demand health care at your doorstep is
not only possible, but also a viable business model. In a few taps, via the Disptach app, a board-certified medical
team will come to your home, office or wherever you need them to be, equipped with all the tools necessary to
tackle whatever specialized care you might need.

As access to medical care becomes increasingly consumer-focused, it seems that many health tech investors
believe that visits to traditional brick-and-mortar health care facilities will be reserved only for the most serious of
situations.

12. Learn to Live (Minneapolis,Minnesota); Capital Raised: $9 Million

There is no shortage of well-funded startups looking to stake out their own territory in the red-hot digital mental
health therapy space. Health plans, large employers and universities, governments and branches of the military, as
well as the VA, among many others, are keen to offer online CBT (cognitive behavioral therapy) to their members,
students and employees.

In a recent Observer profile of the digital mental health space, Learn to Live was highlighted as one of the
innovators in the sector, pushing the industry to adopt more serious, evidenced-based approaches to digital mental
health treatment in contrast to many of its competitors, which, despite having raised significant amounts of capital,
seem to be dabbling in what can best be described as different flavors of "pop psychology." 2019 was a banner
year for Minneapolis-based Learn to Live, inking scores of key new accounts, including a collaboration with
Blue Cross Blue Shield of Massachusetts, as well as landing a coveted billing in Express Scripts'             Digital
Health Formulary.

Learn to Live's co-founder and CEO Dale Cook grew up in Bogot√°, Colombia, the son of missionaries, and the first-
time entrepreneur has certainly infused Learn to Live with a sense of mission and purpose. The company recently
announced the launch a new product tackling substance use, which makes it among the first to market to address
this clinical need.

13. Lifesprk (St. Louis Park, Minnesota); Capital Raised: $36 Million

Senior or geriatric care is among the fastest growing segments in health care. The nearly $740 billion elderly-care
market is ripe for disruption, and Minnesota-based Lifesprk has adroitly carved out a commanding position to
capitalize on this burgeoning segment of the health care landscape. At its core, Lifesprk is all about bringing a
comprehensive suite of support services to elderly patients, empowering them and their families to stay in control
and enabling them to live the life they want and to retire on their own terms. But behind the scenes-and this is why

                                                                                                      Page 16 of 18
                     Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference

founder and CEO Joel Theisen has become something of a superstar within the national senior care marketplace-is
the data.

Lifesprk is collecting and integrating data that has either been siloed, or not even captured at all, to develop a
personalized Electronic Life Record, or ELR, an innovative platform that is as revolutionary to senior care as the
Bloomberg Terminal was to global financial markets. By aggregating huge data sets focused on the individual,
Lifesprk can quickly identify and even suggest personalized services at the appropriate price point to meet the
needs any life scenario a senior might encounter. The result is longer, fuller lives, lower costs and a booming
company.

14. IDx (Iowa City, Iowa); Capital Raised: $55 Million

The eyes are all-important gateway into our mind, body and, some might say, soul. IDx's flagship product, the IDx-
DR, is the first FDA-approved autonomous artificial intelligence (AI) platform that uses software to analyze images
from a high powered camera for evidence of retinal lesions typically associated with the early onset of blindness
from diabetes. Founded by an ophthalmologist originally from the Netherlands who moved to the Midwest to
practice medicine at the University of Iowa, this startup is revolutionizing the early detection of blindness, a common
affliction associated with diabetes, which afflicts roughly 8.5% of the global population.

The company's secret sauce is its ability to scale by sidestepping the need for a clinician to interpret the results of
its retinal scans, making the data more widely available by health care providers who are not normally involved in
eye care.

15. Sera Prognostics (Salt Lake City, Utah); Capital Raised: $151 million

Mothers-to-be and physicians are increasingly turning to Utah-based Sera Prognostics for early prediction of a
woman's individualized risk of premature birth and other pregnancy-related complications. The company is a real
game changer, having developed a suite of diagnostic tests designed to give women and their physicians the time
needed to make individualized treatment and care plans. The company's flagship product, the PreTRM blood test,
is the only clinically recognized bio-marker available to the public at large.

Dr. Garrett Lam, Sera's chief medical officer, commented, "I've shared in the heartbreak and tragedy caused by
complications of pregnancy throughout my career. Our work at Sera, to identify risks early in pregnancy, will assist
doctors, positively impact mothers and benefit the health of newborns to make a significant difference in our
world."

The health care investment community is betting big on Sera becoming the gold-standard for early-risk detection in
expectant mothers and a global leader in high-value women's health diagnostics. Like many other entries on this
year's list, Sera is solving a specific set of issues-in this case, by delivering pivotal information to patients and
physicians-that will play a broader role in improving the economics of the entire health care ecosystem.

16. Aunt Bertha (Austin, Texas); Capital Raised: $22 Million

In the U.S., there are thousands of nonprofits and social care providers set up to serve those in need, but the reality
is that navigating the complex maze of which organization does what is nothing short of daunting for the average
person in need. For many, what should be a simple and straightforward process, becomes time consuming, leaving
many frustrated to the point of giving up. Bottomline: too many Americans are needlessly suffering despite a surfeit
of accessible resources from charities, NGOs and nonprofits. Enter Aunt Bertha, an Austin-based platform that
connects people seeking help and the verified social care providers that serve them. Aunt Bertha is the "favorite
Aunt you can trust," powering the country's most comprehensive online directory of social service organizations.

But Aunt Bertha is more than just a 'Yellow Pages' for social services; the reason the company has become a
favorite among VCs is its ability to tap into a largely overlooked, but critically important, aspect of the health care
ecosystem, offering big brand health care customers solutions with advanced features like EHR (Electronic

                                                                                                       Page 17 of 18
                     Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference

Hospital Record) integrations and giving caregiver teams a more complete view of a patient's global support
environment.

17. AxialHealthcare (Nashville, Tennessee); Capital Raised: $26 Million

Presidential candidates on the campaign trail often talk about the nation's runaway opioid epidemic. According to
the 2018 National Survey on Drug Use and Health, over 10 million Americans aged 12 and older misused opioids
in 2018, and the impact on communities across the country has been devastating. Nashville-based AxialHealthcare
is teaming up with hospitals and caretakers around the country to combat opioid abuse by leveraging state-of-the
art analytics to identify patients at risk, prevent escalation of their conditions and support appropriate treatment
enrollment and adherence. Axial is on the frontline of a deadly diseases (nearly 130 Americans die each day from
opioid-related abuse) and an immense marketplace; last year, over $200 billion was spent combating the opioid
epidemic in the U.S.

Axial's approach is predicated on a high-touch, community-based approach that delivers clinical metrics and
financial outcomes by managing the cost of care while supporting sustained recovery efforts for patients diagnosed
with opioid use disorder. Newly-minted CEO Carter Paine-the former president and COO of value-based care
manager naviHealth, who brings a career's worth of insight from his time working with companies in the IT and
health services world-will look to expand the Axial platform's reach, which now covers nearly three million people.

18. Benovate (Minneapolis, Minnesota); Capital Raised: $6 Million

Although no one can find the original tape recording, the quote, "Let food be thy medicine, and let medicine be thy
food" is famously attributed to the ancient Greek physician Hippocrates-often regarded as the father of all medicine.
Whether Hippocrates actually said it or not, it's increasingly clear that our less than ideal 21st century diets are the
root cause behind a host of modern health issues, and Benovate is one of the leading disruptors in the "food as
medicine" movement, mixing up an elixir of tech, AI, nutrition and health care industry knowledge to market their
trademarked Gx product (a riff off the pharmaceutical 'Rx' with 'G' for grocery).

Benovate is wellbeing 2.0. Its Gx app is breaking new ground in enabling the entire health ecosystem, from doctor
to insurance provider, to prescribe and reimburse everyday foods, like a cucumber, which is packed with valuable
nutrients. Under the seasoned guidance of company CEO Mark Walinske, a 30-year veteran of the health care
space, Benovate's Gx product aims to transform your local grocery into the neighborhood pharmacist.

19. Abilitech Medical (St. Paul, Minnesota); Capital Raised: $9 Million

Fresh off a $7.4 Million Series A financing round, Minnesota's Abilitech Medical has a gust of arctic wind at its back.
CEO Angie Conley has collected so many business awards in the last year that she is probably running out of room
atop her fireplace mantle. And that's a good thing because Abilitech is a company with a lot of heart in addition to
solving a very serious health challenge-enabling those with upper-limb neuromuscular conditions to function
independently.

The company's first product, the Abilitech Assist, is a powered orthotic device providing functional assistance and
support to both the elbow and the shoulder, improving the lives of those affected by muscular dystrophy, multiple
sclerosis, spinal cord injury and, in some cases, those who have suffered a stroke.

In 2020, the company is poised to earn FDA registration, undergo clinical studies and begin widespread
commercialization of the Abilitech Assist, which has made many VCs at this year's confab in San Francisco eager
to get some quality time with Conley. Observer isn't the only publication to have realized the potential of this game-
changing company; they've already received recognition as a Top 10 Medical Device Startup in the country by
Medical Tech Outlook magazine, a Top 10 Promising Company by the Rice Alliance, and was touted as a Top 20
Medical Device Startup by MassDevice.

20. Omcare (Bloomington, Minnesota); Capital Raised: $9 Million

                                                                                                     Page 18 of 18
                     Flannel Is the New Black at the 2020 J.P. Morgan Healthcare Conference

What's the size of breadbox, looks like a coffee-maker designed by Apple and dispenses pills? No idea? It's the
Omcare home medicine dispenser, equipped with a pair of Wi-Fi-enabled interactive cameras that will enable
caregivers to watch grandma in real-time not only handle the packet of pre-loaded pills (at the right time), but also
swallow them as well (ergo the second camera!) to ensure there is none of that "hide the pill under the tongue
trickery." The Omcare technology, which was adapted from founder and CEO Lisa Lavin's previous intelligent treat
dispenser for pets startup, has a deadly serious mission: reduce errors in medication and maximize adherence in
the elderly community.

Omcare was recently given a big boost by the addition of long-time health care veteran Jeannine Rivet to its board.
Rivet, the former executive vice president of UnitedHealth Group, one of the world's largest publicly-traded health
care corporations, believes that remote care is the way of the future and that companies like Omcare, which enable
elderly patients to stay independent longer, make sense not only in terms of the economics, but also by meeting the
needs of seniors who desire to age in place.

"I began my career in health care as a nurse, and so I know first-hand the challenges and constraints placed upon
caregivers," Rivet explained. "Although in its early stages, Omcare has the potential to revolutionize medication
non-adherence among elderly and others struggling to manage chronic or complex health conditions."

Omcare's Home Health Hub utilizes audio and visual messages, which lets caregivers and care teams monitor
medication adherence, and its multi-dose packaging is specially designed in collaboration with pharmacies so that
correct dosage consumption is no longer an issue.

Finding Diamonds in the Rough

The annual J.P. Morgan Healthcare Conference sets the tone for the rest of the year when it comes to the biggest
trends crisscrossing the global health care industry. Last year, the surfeit of bold health care innovators emerging
from places like St Louis, Missouri and Columbus, Ohio, for example, wasn't a surprise to industry insiders, but it
did appear to catch some of the coastal business media who only breathe in that rarified air of Silicon Valley
somewhat by surprise. But this year, VCs, Big Pharma, big health care and the business media are well aware that
some of the biggest stars at this year's conference will hail from 'flyover country.'

Aly Lovett, a partner at New York City-based Radian Capital, a growth equity firm with a strong presence in the
health care software space, openly embraces looking for investment opportunities in cities typically overlooked by
most traditional health care VCs. "The knowledge base required to build a leading technology company is no
longer concentrated in just a few cities, and capital is starting to follow that trend. Lower costs, higher quality of
living and more diffused access to great talent make these smaller cities highly desirable places to start
businesses," commented Lovett. "There are many amazing angels and seed funds in these regions that can help
get companies started, and we think there is an opportunity for Radian to provide growth equity to support these
businesses in their next phase of growth."

But if Lovett has been holding on to something of a secret, it would seem that her secret is now out in the open;
capital far and wide is searching for the new, new thing in health tech from flyover country, and many will be using
the J.P. Morgan confab as an opportunity to get to know them.

No matter where they call home.


Load-Date: January 13, 2020


  
